ECT in TRD: New Review
Coming out in the Journal of Neurological Sciences is this review:
The abstract is copied below:
Electroconvulsive therapy (ECT) is a treatment modality for patients with treatment
resistant depression (TRD), defined as failure of two adequate antidepressant
medication trials. We provide a qualitative review of ECT’s effectiveness for TRD,
methods to optimize ECT parameters to improve remission rates and side effect
profiles, and ECT’s proposed neurobiological mechanisms. Right unilateral (RUL)
electrode placement has been shown to be as effective for major depression as bilateral
ECT, and RUL is associated with fewer cognitive side effects. There is mixed evidence
on how to utilize ECT to sustain remission (i.e., continuation ECT, psychotropic
medications alone, or a combination of ECT and psychotropic medications). Related to
neurobiological mechanisms, an increase in gray matter volume in the hippocampus/amygdala
complex is reported post-ECT. High connectivity between the subgenual
anterior cingulate and the middle temporal gyrus before ECT is associated with better
treatment response. Rodent models have implicated changes in neurotransmitters
including glutamate, GABA, serotonin, and dopamine in ECT’s efficacy; however,
findings in humans are limited. Altogether, while ECT remains a highly effective therapy,
the neurobiological underpinnings associated with improvement of depression remain uncertain.
Omnivores of the ECT literature will, of course, want to read this in full, ~ 25 minutes; for others, the abstract and vignette, above, should suffice.
Comments
Post a Comment